Nordwand Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,000	Closed	-$2.95K	–	116
2024 Q4	$2.95K	Hold	4,000	–	–	﹤0.01%	106
2024 Q3	$6.28K	Hold	4,000	–	–	﹤0.01%	100
2024 Q2	$6.72K	Hold	4,000	–	–	﹤0.01%	119
2024 Q1	$9.6K	Buy	+4,000	New	+$9.6K	﹤0.01%	126